QT Vascular launches IPO at 28 cents each for Catalist listing
QT Vascular has launched its initial public offering (IPO) for a Catalist listing with an offer of 196.4 million shares
Pioneering Medical Innovations
Pioneering Medical Innovations
QT Vascular has launched its initial public offering (IPO) for a Catalist listing with an offer of 196.4 million shares
“With AccessClosure we received an outstanding management team with a proven track record to commercialize interventional cardiology assets,” Don Casey,
Congressional candidate Ro Khanna described his jobs plan Monday at Access Closure. The plan includes teaching computer coding in public
Amar Sawhney is featured in an article on the Immpreneur website Learn how Amar Sawhney, who arrived in the U.S
On May 29, 2013, Mr. Sawhney was awarded two awards by the White House, “Champion of Change” and “Outstanding American
Teleflex Incorporated (Limerick, PA) announced that it has received CE Mark approval to market the company’s Arrow GPSCath balloon dilatation
Novel Platform Based Technology Combines Multiple Functions in Single Device; Acquisition includes Portfolio of FDA 510(k) Cleared Catheters for Dialysis
PLEASANTON, Calif., May 23, 2012 /PRNewswire/ — TriReme Medical, Inc. (TMI) today announced approval by the U.S. Food and Drug
Professor Achim Buettner from Bad Krozingen, Germany placed the Claret Montage device “live” in the Main Arena to protect the
May 9, 2012 – Still riding an acquisition wave, global healthcare products provider Covidien (NYSE: COV) has acquired nascent hypertension